We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2015 by Thomas Jefferson University.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00359320
First Posted: August 2, 2006
Last Update Posted: March 18, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Thomas Jefferson University
  Purpose
The purpose of this trial is to determine whether a mucosa-to-mucosa technique of pancreaticojejunostomy will improve the pancreatic fistula rate.

Condition Intervention
Pancreatic Neoplasms Biliary Tract Neoplasms Pancreatitis, Chronic Duodenal Neoplasms Procedure: pancreaticojejunostomy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy

Resource links provided by NLM:


Further study details as provided by Thomas Jefferson University:

Primary Outcome Measures:
  • The primary endpoint will be the pancreatic fistula rate.

Secondary Outcome Measures:
  • length of hospitalization
  • percutaneous intervention rates
  • reoperation rates
  • morbidity
  • death

Study Start Date: July 2006
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients must have undergone pancreaticoduodenectomy.
  • Must have pancreatic remnant remaining in place (body and tail).
  • Must be candidate for reconstruction by pancreaticojejunostomy by one of the two techniques described below.
  • Must have an identifiable pancreatic duct which can be used for a duct-to-mucosa anastomosis.

Exclusion Criteria:

  • Patients undergoing total pancreatectomy.
  • Patients undergoing PD who have had previous left-sided pancreatic resection.
  • Failure to sign informed consent.
  • Failure to identify the pancreatic duct.
  • Pregnant patients.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00359320


Contacts
Contact: Adam C Berger, MD 215-955-1622 adam.berger@jefferson.edu

Locations
United States, Pennsylvania
Thomas Jefferson University Hospital Recruiting
Philadelphia, Pennsylvania, United States, 19107
Sub-Investigator: Charles Yeo, MD         
Sub-Investigator: Eugene P Kennedy, MD         
Sub-Investigator: Ernest Rosato, MD         
Sub-Investigator: Karen Chojnacki, MD         
Sub-Investigator: Cataldo Doria, MD         
Sub-Investigator: Bernadette Profeta, MD         
Sub-Investigator: Patricia Sauter, CRNP         
Sponsors and Collaborators
Thomas Jefferson University
Investigators
Principal Investigator: Adam C Berger, MD Thomas Jefferson University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Thomas Jefferson University
ClinicalTrials.gov Identifier: NCT00359320     History of Changes
Obsolete Identifiers: NCT00432848
Other Study ID Numbers: 06U.198
First Submitted: August 1, 2006
First Posted: August 2, 2006
Last Update Posted: March 18, 2015
Last Verified: March 2015

Keywords provided by Thomas Jefferson University:
Pancreaticoduodenectomy
Pancreaticojejunostomy
Pancreatic Cancer

Additional relevant MeSH terms:
Neoplasms
Pancreatitis
Pancreatic Neoplasms
Biliary Tract Neoplasms
Pancreatitis, Chronic
Duodenal Neoplasms
Pancreatic Diseases
Digestive System Diseases
Digestive System Neoplasms
Neoplasms by Site
Endocrine Gland Neoplasms
Endocrine System Diseases
Biliary Tract Diseases
Intestinal Neoplasms
Gastrointestinal Neoplasms
Gastrointestinal Diseases
Duodenal Diseases
Intestinal Diseases